62% of Medicines Dispensed in Europe are Generic, according to IMS New Data

15 June 2017

Pharmaceutical industry leaders and key stakeholders from the generic, biosimilar […]

EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access

23 May 2017

The European Semester Country Specific Recommendations show that healthcare systems […]

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

18 May 2017

Speaking at the B20 Health Conference in Berlin, IFPMA Director-General […]

Biosimilar Medicines Opportunity: Dramatic Increase in Patient Access across Europe

9 May 2017

The new report on The Impact of Biosimilar Competition in […]

Industry Welcomes the 3^rd European Commission Workshop on Biosimilar Medicines

5 May 2017

The European pharmaceutical industry welcomes the 3rd workshop on access […]

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

Over 100 participants explored different ways and opportunities to ensure […]

22^nd EAHP Conference in Cannes

25 March 2017

A special satellite symposium was organized on “Value added medicines […]

Biosimilar Medicines: a Game Changer for Oncology Care

23 March 2017

With 10 years of positive experience with biosimilar medicines, medical […]

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

Key authorities, eminent lawyers and industry leaders discussed today in […]

European Experience and Evidence of Physician-led Switching of Biological Medicines Give Hope to Patients around the World

14 March 2017

On 9th March, IFPMA launched jointly with EFPIA and EBE […]

Newsroom

News about

By type

Twitter

Videos

Photos

62% of Medicines Dispensed in Europe are Generic, according to IMS New Data

15 June 2017

EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access

23 May 2017

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

18 May 2017

Biosimilar Medicines Opportunity: Dramatic Increase in Patient Access across Europe

9 May 2017

Industry Welcomes the 3^rd European Commission Workshop on Biosimilar Medicines

5 May 2017

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

22^nd EAHP Conference in Cannes

25 March 2017

Biosimilar Medicines: a Game Changer for Oncology Care

23 March 2017

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

European Experience and Evidence of Physician-led Switching of Biological Medicines Give Hope to Patients around the World

14 March 2017

Subscribe to our newsletter

Share on Mastodon

News about

By type

Twitter

Videos

Photos

62% of Medicines Dispensed in Europe are Generic, according to IMS New Data

15 June 2017

EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access

23 May 2017

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

18 May 2017

Biosimilar Medicines Opportunity: Dramatic Increase in Patient Access across Europe

9 May 2017

Industry Welcomes the 3rd European Commission Workshop on Biosimilar Medicines

5 May 2017

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

22nd EAHP Conference in Cannes

25 March 2017

Biosimilar Medicines: a Game Changer for Oncology Care

23 March 2017

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

European Experience and Evidence of Physician-led Switching of Biological Medicines Give Hope to Patients around the World

14 March 2017

Subscribe to our newsletter

Industry Welcomes the 3^rd European Commission Workshop on Biosimilar Medicines

22^nd EAHP Conference in Cannes